Epidemiological parameters of COVID-19 and its implication for infectivity among patients in China, 1 January to 11 February 2020
Qing‐Bin Lu(King University), Li-Qun Fang(Institute of Microbiology), An-Ran Zhang(Shandong University), Ming-Jin Liu(University of Florida), Xiu-Gang Guan(Institute of Microbiology), Neda Jalali(University of Notre Dame), Han Zhao(Beijing Normal University), Xiao‐Ai Zhang(Institute of Microbiology), Haiyang Zhang, Yuanyuan Zhang(University of Nebraska–Lincoln), Jiachen Li(Institute of Microbiology), Yang Yang(Chengdu Sport University), Yong Zhang(Harbin Medical University), Wei Liu(Academy of Military Medical Sciences), Tao Wang(Wuhan Sixth Hospital), Hanyu Liu(Peking University), Juan Du(Peking University), Qian-Qian Song(Beijing Normal University), Jing Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zi-Wei Zhou(Institute of Microbiology), Shi-Xia Zhou(Institute of Microbiology), Tong Yang(Institute of Microbiology), Yu-na Wang(Institute of Microbiology), Xiao-Gang Duan(Beijing Normal University), Tian-Shuo Zhao(Peking University), Tian-Le Che(Institute of Microbiology), Xue-Fang Peng(Institute of Microbiology), Wen-Qiang Shi(Institute of Microbiology), Shou-Ming Lv(Institute of Microbiology), Bao-Cheng Liu(Institute of Microbiology), Ai-Ying Teng(Institute of Microbiology)
Cited by 62
Related Papers
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study
|The Lancet Infectious Diseases|2020|538
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data
|The Lancet Public Health|2023|522